CVEvulnerability

CVE-2025-21570

6.1 MEDIUM Published 2025-01-21 Modified 2026-06-17 Official page ↗
Status
Analyzed
Published
2025-01-21
Last modified
2026-06-17
Assigner
[email protected]
CVSS 3.1 ([email protected])
6.1 MEDIUM — CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
Weaknesses
CWE-863

Description

Vulnerability in the Oracle Life Sciences Argus Safety product of Oracle Health Sciences Applications (component: Login). The supported version that is affected is 8.2.3. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Argus Safety. Successful attacks require human interaction from a person other than the attacker and while the vulnerability is in Oracle Life Sciences Argus Safety, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Argus Safety accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Argus Safety accessible data. CVSS 3.1 Base Score 6.1 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N).

Affected configurations

• oracle argus safety 8.2.3

Related

Weakness · CWE (1)

  • CWE-863 Incorrect Authorization weakness

References